Symbolbild · KI-generiert
TECSYS Inc.
Stock factsheet
Company data from public sources (TMX Money, Canadian Securities Exchange, Nasdaq screener, Wikidata); every ISIN is verified against its check digit. Where „—“ appears, no verified value exists — we do not publish unverified identifiers. Market capitalisation is an order of magnitude as of the date shown, not a real-time figure. The size class follows the thresholds in common use (micro < $300m, small < $2bn, mid < $10bn) and is meant as an indication, not a definition.
Company profile
Tecsys is trusted by mission-critical organizations in healthcare and distribution to build resilient, efficient and secure supply chains. A global provider of cloud-based, AI-driven software with deep domain expertise, Tecsys delivers real-time operational visibility and execution across critical workflows when performance and reliability matter most. Tecsys is publicly traded on the Toronto Stock Exchange (TCS). For more information, visit www.tecsys.com.
Company description as published by the issuer via TMX Money.
Share price
Price data from TradingView, possibly delayed. Not investment advice.
Comparable companies
Companies in the Biotech & Pharma sector of a similar size.
| Company | Ticker | Exchange | Market cap |
|---|---|---|---|
| TECSYS Inc. | TCS | TSX | 344 Mio. USD |
| Upstream Bio, Inc. | UPB | NASDAQ | 343 Mio. USD |
| Compass Therapeutics, Inc. | CMPX | NASDAQ | 344 Mio. USD |
| Carlsmed, Inc. | CARL | NASDAQ | 342 Mio. USD |
| DiaMedica Therapeutics Inc. | DMAC | NASDAQ | 342 Mio. USD |
| Fennec Pharmaceuticals Inc. | FRX | TSX | 346 Mio. USD |
| Standard BioTools Inc. | LAB | NASDAQ | 340 Mio. USD |
Investor Relations
We link only to primary sources from the company itself and from the regulators. Fields we have not recorded stay empty until a reliable source is available.
Information and education only — not investment advice, not a recommendation and not a financial analysis within the meaning of §85 WpHG or Art. 20 MAR. Investments in small and micro caps are highly speculative; total loss is possible. All information without warranty.